In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk

被引：1
|
作者：
Davidson, Mayer B. [1 ]
机构：
[1] Charles R Drew Univ, Los Angeles, CA 90059 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 10期
关键词：
D O I：
10.7326/J22-0072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC116 / JC116
页数：1
相关论文
共 50 条
  • [31] Trends in Obesity Drug Initiation after the Approval of Tirzepatide in Adults without Type 2 Diabetes
    Paik, Julie M.
    Ortega-Montiel, Janinne
    Tesfaye, Helen
    Alix, Caroline
    Dicesare, Elyse O.
    Cromer, Sara Jane
    Wexler, Deborah J.
    Patorno, Elisabetta
    DIABETES, 2024, 73
  • [32] Lifestyle Intervention Favorably Affects Weight Loss and Maintenance Following Obesity Surgery
    Papalazarou, Anastasios
    Yannakoulia, Mary
    Kavouras, Stavros A.
    Komesidou, Vasiliki
    Dimitriadis, George
    Papakonstantinou, Alexandros
    Sidossis, Labros S.
    OBESITY, 2010, 18 (07) : 1348 - 1353
  • [33] Differences in Weight Reduction Efficacy of Tirzepatide in Adults Without vs. With Type 2 Diabetes with Overweight or Obesity in SURMOUNT 1 and 2
    Galindo, Rodolfo J.
    Garvey, W. Timothy
    Neff, Lisa M.
    Stefanski, Adam
    Cao, Dachuang
    Lee, Clare
    DIABETES, 2024, 73
  • [34] Comment on "Obesity/Type 2 Diabetes: GLP-1 Agonist Tirzepatide Promotes Weight Loss"
    Blueher, Matthias
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 415 - 416
  • [35] Breakfast Consumption is Associated With Weight Loss During an Intensive Lifestyle Intervention for Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Look AHEAD Trial
    Duan, Daisy
    Pilla, Scott J.
    Clark, Jeanne M.
    Maruthur, Nisa M.
    CIRCULATION, 2020, 142
  • [36] 'Take 5' - a weight loss intervention for adults with intellectual disabilities and obesity
    Spanos, D.
    Hankey, C.
    Macmillan, S.
    Rankin, L.
    Miller, S.
    Penpraze, V.
    Boyle, S.
    Murray, H.
    Pert, C.
    Robinson, N.
    Melville, C.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (OCE6) : E505 - E505
  • [37] A pilot study of the TAKE 5 weight loss intervention for adults with obesity
    Melville, C.
    Spanos, D.
    Rankin, L.
    MacMillan, S.
    Penpraze, V.
    Boyle, S.
    Pert, C.
    Robinson, N.
    Miller, S.
    Hankey, C.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2010, 23 (05) : 468 - 468
  • [38] Metabolic and cardiovascular adaptations to an 8-wk lifestyle weight loss intervention in younger and older obese men
    Vion, Julie
    Sramkova, Veronika
    Montastier, Emilie
    Marques, Marie-Adeline
    Caspar-Bauguil, Sylvie
    Duparc, Thibaut
    Martinez, Laurent O.
    Bourlier, Virginie
    Harant, Isabelle
    Larrouy, Dominique
    Moussaoui, Nabila
    Bonnel, Sophie
    Vindis, Cecile
    Dray, Cedric
    Valet, Philippe
    Saulnier-Blache, Jean-Sebastien
    Schanstra, Joost P.
    Thalamas, Claire
    Viguerie, Nathalie
    Moro, Cedric
    Langin, Dominique
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 321 (03): : E325 - E337
  • [39] Weight Loss Trajectory of People With Obesity Taking TZP Following Intensive Lifestyle Intervention
    Ard, Jamy
    Xie, Chang
    Brumm, Julia Fraseur
    Forrester, Tammy
    Dunn, Julia
    Falcon, Beverly
    OBESITY, 2024, 32 : 187 - 187
  • [40] In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk
    Ali, Hyeon-Ju
    Deswal, Anita
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : JC136 - JC136
12345